MedTrace Logo

Observational Study of Dydrogesterone in Cycle Regularization

NCT02029144 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2015-02-10

No results posted yet for this study

Summary

Dydrogesterone has been widely used worldwide for various gynecological and obstetric indications:

* Dydrogesterone is effective in cycle regulation treatment.
* Dydrogesterone is recognized as none interference to hypothalamus pituitary ovary (HPO) axis in the recommended dosage.
* Dydrogesterone might have non-negative effect on glucose and lipid metabolic.

Conditions

  • Observational Study
  • Dydrogesterone
  • Irregular Menstrual Cycle
  • Abnormal Uterine Bleeding

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • Fudan University

    lead OTHER

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02029144 on ClinicalTrials.gov